illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. Amedisys
Company logo

Amedisys | Sustainability Performance

https://www.amedisys.com

Amedisys Inc. provides home health care and hospice services, offering medical, therapeutic, and support services to patients in their homes. The company focuses on delivering high-quality, personalized care for individuals with chronic conditions and those in end-of-life care.

1982

United States

10,001+ employees

Hospital & Health Care

$1B - 10B in revenue

Not profitable

Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.

Sustainability Ranking & Industry Benchmark

#7682
Overallⓘ
#1685
in United Statesⓘ
#82
in Hospital & Health Careⓘ

Sustainability Maturity

ⓘ
​​0123456789​​%

Sustainability Intent

ⓘ

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

58 out of 136

Overview
Governance
Targets
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Cano Health

United States, Health Care, Hospital & Health Care


Company logo
Encompass health

United States, Health Care, Hospital & Health Care


Company logo
Surgery Partners

United States, Health Care, Hospital & Health Care

Market cap ⓘTotal market value of the company's outstanding shares, calculated by multiplying the share price by the number of shares outstanding.
3.3B$, 2025▼3.1% YoY
Revenue ⓘTotal revenue reported in the company's financial statements for the specified reporting year, reflecting income generated from primary business activities. Expressed in millions of USD.
2.3B$, 2024▼4.8% YoY

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • Amedisys paid USD 150 million DOJ False Claims Act settlement in 2014 over Medicare home health billing fraud, with sustained subsequent regulatory scrutiny over hospice and home health services billing.
Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

Sustainability employees

ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.


    Available in
    Scale package

    Access
  • Email

  • Email